Table S5. Univariate and Multivariate Analysis of Prognostic Factors for recurrence-free survival and Overall Survival (NÂ =â29). (DOCX 18 kb
Figure S4. Tumor-derived exosomes activated HSCs in vivo. a Immunohistochemistry imaging of Ki67 sho...
Table S5. Univariate- and Multivariate- analysis of risk factors for relapse-free survival (RFS) and...
Figure S2. Tumor-derived exosomes activated HSCs in vitro. a Flow cytometry assays of cell cycle sho...
Table S6. Univariate and Multivariate Analysis of Prognostic Factors for recurrence-free survival an...
Figure S1. TIM-1+ B cells strongly infiltrated lung carcinoma tissue. (A) The TIM-1+B cells in the t...
Figure S6. Tumor-derived exosomes did not promote TIM-1+B cell expansion via autophagy. (A) B cells ...
Figure S5. Tumor-derived exosomes promoted TIM-1+B cell expansion via TLR2/4. (A) On day 3, CD19+ B ...
Figure S4. HMGB1 produced in culture was not derived from the active or passive release of HMGB1 by ...
Figure S2. TIM-1+Breg cells are a regulatory B cell subset that promoted HCC progression by impairin...
Figure S7. A schematic showing the novel mechanism of TIM-1+ Breg cells in HCC progression. Based on...
Figure S7. Exosomal HMGB1 expression in tumor tissues and serum samples of gastric cancer patients. ...
Figure S1. Prognostic analysis of MYC expression in HCC. (a) Analysis of the risk based on MYC expre...
Additional file 1: Supplementary Figure S1. Exosomes derived from CD133+ cells enhance the malignant...
Immunohistochemical staining demonstrated that peritumoral expression of HMGB1 was higher in the pat...
Figure S8. Recombinant HMGB1 induced autophagy and promoted the activation of neutrophils. A. The pe...
Figure S4. Tumor-derived exosomes activated HSCs in vivo. a Immunohistochemistry imaging of Ki67 sho...
Table S5. Univariate- and Multivariate- analysis of risk factors for relapse-free survival (RFS) and...
Figure S2. Tumor-derived exosomes activated HSCs in vitro. a Flow cytometry assays of cell cycle sho...
Table S6. Univariate and Multivariate Analysis of Prognostic Factors for recurrence-free survival an...
Figure S1. TIM-1+ B cells strongly infiltrated lung carcinoma tissue. (A) The TIM-1+B cells in the t...
Figure S6. Tumor-derived exosomes did not promote TIM-1+B cell expansion via autophagy. (A) B cells ...
Figure S5. Tumor-derived exosomes promoted TIM-1+B cell expansion via TLR2/4. (A) On day 3, CD19+ B ...
Figure S4. HMGB1 produced in culture was not derived from the active or passive release of HMGB1 by ...
Figure S2. TIM-1+Breg cells are a regulatory B cell subset that promoted HCC progression by impairin...
Figure S7. A schematic showing the novel mechanism of TIM-1+ Breg cells in HCC progression. Based on...
Figure S7. Exosomal HMGB1 expression in tumor tissues and serum samples of gastric cancer patients. ...
Figure S1. Prognostic analysis of MYC expression in HCC. (a) Analysis of the risk based on MYC expre...
Additional file 1: Supplementary Figure S1. Exosomes derived from CD133+ cells enhance the malignant...
Immunohistochemical staining demonstrated that peritumoral expression of HMGB1 was higher in the pat...
Figure S8. Recombinant HMGB1 induced autophagy and promoted the activation of neutrophils. A. The pe...
Figure S4. Tumor-derived exosomes activated HSCs in vivo. a Immunohistochemistry imaging of Ki67 sho...
Table S5. Univariate- and Multivariate- analysis of risk factors for relapse-free survival (RFS) and...
Figure S2. Tumor-derived exosomes activated HSCs in vitro. a Flow cytometry assays of cell cycle sho...